- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.25 Amended and Restated Backup Facility Agreement and Amendment to Other Operative Agreements, Dated As of November 4, 2004, Among Dna Finance Corp, JP Morgan Bank and Various Financial Institutions Named Therein.
- 10.27 Master Lease Agreement, Dated As of November 1, 2004, Between Genentech and Slough SSF, LLC.
- 23.1 Consent Independent Registered Public Accounting Firm.
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- PDF "Unofficial" PDF Copy of the Form 10-K (December 31, 2004)
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-115219, 333-87444, 333-94749, 333-90669, 333-83989, and 333-83157) pertaining to the 2004 Equity Incentive Plan, the 1999 Stock Plan, the 1996 Stock Option/Stock Incentive Plan, the 1994 Stock Option Plan, the 1991 Employee Stock Plan, the 1990 Stock Option/Stock Incentive Plan, and the Genentech, Inc. Tax Reduction Investment Plan, and the Registration Statement on Form S-3 (No. 333-37072) pertaining to resales of common shares deliverable upon the exchange of Liquid Yield Option Notes, and in the related Prospectuses, of Genentech, Inc. of our reports dated February 18,2005, with respect to the consolidated financial statements and schedule of Genentech, Inc., Genentech, Inc. management's assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Genentech, Inc., included in the Annual Report (Fo rm 10-K) for the year ended December 31, 2004.
/s/ ERNST & YOUNG LLP |
Palo Alto, California
February 24, 2005